John M. Evans - Aug 19, 2021 Form 4 Insider Report for Beam Therapeutics Inc. (BEAM)

Role
CEO, Director
Signature
/s/ Christine Bellon, Attorney-in-fact
Stock symbol
BEAM
Transactions as of
Aug 19, 2021
Transactions value $
-$1,977,384
Form type
4
Date filed
8/20/2021, 06:05 PM
Previous filing
Jul 8, 2021
Next filing
Oct 8, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BEAM Common Stock Sale -$38.6K -400 -0.18% $96.38 223K Aug 19, 2021 By John M. Evans, III 2018 Irrevocable Trust F1, F2
transaction BEAM Common Stock Sale -$97.5K -1K -0.45% $97.50 222K Aug 19, 2021 By John M. Evans, III 2018 Irrevocable Trust F1, F3
transaction BEAM Common Stock Sale -$310K -3.14K -1.42% $98.74 218K Aug 19, 2021 By John M. Evans, III 2018 Irrevocable Trust F1, F4
transaction BEAM Common Stock Sale -$966K -9.7K -4.44% $99.53 209K Aug 19, 2021 By John M. Evans, III 2018 Irrevocable Trust F1, F5
transaction BEAM Common Stock Sale -$548K -5.46K -2.61% $100.35 203K Aug 19, 2021 By John M. Evans, III 2018 Irrevocable Trust F1, F6
transaction BEAM Common Stock Sale -$30.3K -300 -0.15% $101.00 203K Aug 19, 2021 By John M. Evans, III 2018 Irrevocable Trust F1
transaction BEAM Common Stock Options Exercise $12.4K +12K +1.17% $1.03* 1.03M Aug 19, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BEAM Stock Option (Right to Buy) Options Exercise $0 -12K -3.23% $0.00 359K Aug 19, 2021 Common Stock 12K $1.03 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. The sale price reported is a weighted average price. The Reporting Person undertakes to provide to Beam Therapeutics Inc. ("BEAM"), any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $96.07 to $96.97, inclusive.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $97.22 to $97.85, inclusive.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $98.33 to $98.99, inclusive.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $99.01 to $99.95, inclusive.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $100.04 to $100.99, inclusive.
F7 The option vests as to 25% on the first anniversary of the of the vesting commencement date, January 8, 2018, and at a rate of 2.78% each month thereafter until the option is fully vested.